<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:department>Division of Cancer Biology</gtr:department><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B8C3C602-541B-498F-9F55-2F76387FE34E"><gtr:id>B8C3C602-541B-498F-9F55-2F76387FE34E</gtr:id><gtr:firstName>Amanda</gtr:firstName><gtr:surname>Swain</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401179"><gtr:id>C7F08B79-A3E7-461B-96CE-07EC3E90C720</gtr:id><gtr:title>Role of the coactivator CITED2 in adrenal development and neoplasia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401179</gtr:grantReference><gtr:abstractText>The adrenal is an essential organ in vertebrates required for maintenance of homeostasis. Defects in adrenal differentiation can be lethal if left untreated. Relatively few transcription factors have been identified to be important in adrenal development and function. The transcriptional coactivator CITED2 has been implicated in the development of the mammalian embryo in various tissues. Mice deficient for Cited2 show absence of adrenal development. The aim of this project is to determine the role of this factor in adrenal differentiation and to establish the molecular and cellular pathways that it regulates within this tissue. These studies will provide insight into the process of mammalian adrenal development and will allow us to further understand the basis for deficiencies in adrenal development in man. Members of the CITED family have been implicated in carcinogenesis through their role in the regulation of cell proliferation and control of hypoxia inducible pathways such as angiogenesis. Therefore we propose to investigate if CITED2 has a role in adrenal cortical tumour formation in humans. Tumours of the adrenal cortex are relatively common and mostly benign. However, a proportion gives rise to malignant adrenal carcinomas that have extremely poor prognosis. Given that developmental pathways are often implicated in carcinogenesis, we will analyse the pathways that we have identified to be activated by CITED2 in embryonic adrenal differentiation in the adrenal tumours. The aim of these studies is to provide diagnostic markers that may help the treatment of this disease.</gtr:abstractText><gtr:technicalSummary>The development of the adrenal is a highly regulated process requiring the interaction of tissues from different embryonic origin. Relatively few transcription factors have been identified to be important in adrenal development and function. The transcriptional coactivator CITED2 has been implicated in the development of the mammalian embryo in various tissues. Mice deficient for Cited2 show absence of adrenal development. The aim of this project is to identify the role of this factor in adrenal differentiation and to establish the molecular and cellular pathways that it regulates within this tissue. We will perform extensive marker analysis of the Cited2 deficient mice at different stages of embryogenesis to determine the primary cause of adrenal development failure. We will identify cellular interactions that are implicated in the phenotype observed in these mice through in vitro organ culture studies. Using a yeast two-hybrid approach we will identify the factors that interact with CITED2 in the developing adrenal. These studies will not only provide insight into the differentiation of the mammalian adrenal but will identify factors that regulate this process. Members of the CITED family have been implicated in carcinogenesis through their role in the regulation of cell proliferation and control of hypoxia inducible pathways such as angiogenesis. Therefore we propose to investigate if CITED2 has a role in adrenal cortical tumour formation in humans. Tumours of the adrenal cortex are relatively common and mostly benign. However, a proportion gives rise to malignant adrenal carcinomas that are highly invasive and have extremely poor prognosis. Using immunohistochemistry we will analyse the expression and localisation of CITED2 in tissue samples derived from different types of adrenal tumours. Given that developmental pathways are often implicated in carcinogenesis, we will also analyse the pathways that we have identified to be activated by CITED2 in embryonic adrenal differentiation in the adrenal tumours. The aim of these studies is to provide diagnostic markers for adrenal tumour formation and progression to malignant adrenal carcinomas.</gtr:technicalSummary><gtr:fund><gtr:end>2008-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>231123</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>92F96045-832C-430C-8FD4-A54FE82A107F</gtr:id><gtr:title>The transcription co-factor CITED2 functions during sex determination and early gonad development.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2174090532bd68c1ddf762a9062d8952"><gtr:id>2174090532bd68c1ddf762a9062d8952</gtr:id><gtr:otherNames>Buaas FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>20CECF693BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E74CAD2-6D38-4625-A342-3BB7D12B2344</gtr:id><gtr:title>Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3692a55b31bc90904e217c8efe28f30e"><gtr:id>3692a55b31bc90904e217c8efe28f30e</gtr:id><gtr:otherNames>Val P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>DBEE33DA867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC73ADCC-9341-40DA-BCB7-70C769340D9D</gtr:id><gtr:title>Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3692a55b31bc90904e217c8efe28f30e"><gtr:id>3692a55b31bc90904e217c8efe28f30e</gtr:id><gtr:otherNames>Val P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>EvuYNAfYnUv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F676D8D1-5450-46C3-A623-98AB721825AF</gtr:id><gtr:title>Identification of a novel population of adrenal-like cells in the mammalian testis.</gtr:title><gtr:parentPublicationTitle>Developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3692a55b31bc90904e217c8efe28f30e"><gtr:id>3692a55b31bc90904e217c8efe28f30e</gtr:id><gtr:otherNames>Val P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0012-1606</gtr:issn><gtr:outcomeId>C0B7558FFBF</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401179</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>